INFU - InfuSystem Holdings Long-Term Debt Volume

Graphic logo of InfuSystem (INFU)

The market capitalization trend for InfuSystem Holdings (INFU) demonstrates the 0.02 metric. The company's profit stability is based on long-term partnerships with oncology centers and recurring service payments. The business generates revenue by providing infusion systems and chemotherapy logistics. A dominant position in the outpatient equipment niche and an extensive distribution network reliably protect the company's market share from local players.

INFU InfuSystem Company Long-Term Debts (07/04/2022 - 10/29/2026)

InfuSystem Holdings, Inc. - analytical breakdowns and key metrics (INFU)

- share price and expert price forecast:
Share Price InfuSystem|INFU - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization InfuSystem Holdings|INFU - Enterprise Value
- balance sheet equity data:
Accounting Value per Share InfuSystem Holdings|INFU - Book Capitalization|Market Capitalization to Book Value Ratio infusystem.com|INFU - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity InfuSystem Holdings|INFU - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital InfuSystem|INFU - Company Aggregate Debts|Debts to Net Assets InfuSystem Holdings|INFU - Company Long-Term Debt|Company Short-Term Indebtedness InfuSystem Holdings|Interim Coverage Ratio infusystem.com
- earnings and multiples data:
INFU - Net Income
Summary company analytics:INFU InfuSystem Holdings
Manufactured products of InfuSystem Inc

InfuSystem Holdings (INFU) is expanding its network of infusion pump rental and service centers, leveraging a recurring payment model. This indicator captures total obligations with maturities exceeding twelve months, reflecting the company's long-term financing strategy. By analyzing the organization's long-term loans and borrowings, one can assess the effectiveness of deleveraging and balance sheet resilience during the post-crisis recovery period. The stability of this metric confirms protection against default, yet signals a potential slowdown in profit growth rates.

Competitors of InfuSystem Holdings (INFU)

ISRG: Company Long-Term Indebtedness|Danaher - Company Long-Term Debts|Long-Term Debt Volume BD BDX|STE: Company Long-Term Debts|Company Long-Term Liabilities West Pharma Corp|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts masimo.com|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt TFX (Teleflex Inc.)|Merit Medical Systems Inc - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings NVST|ICU Medical, Inc. - Company Long-Term Debts|Long-Term Debt Volume dentsplysirona.com XRAY|LeMaitre Vascular (LMAT) - Company Long-Term Debt|Company Long-Term Indebtedness ATRC|Company Long-Term Debt STAAR Surgical Corp|niagenbioscience.com (NAGE) - Long-Term Debt Volume|Company Long-Term Liabilities ZIMV (ZimVie Inc.)|Amount of Long-Term Liabilities ANGO|Company Long-Term Debt Cerus CERS|Company Long-Term Loans and Borrowings TKNO|MGRM: Company Long-Term Liabilities|STSS - Company Long-Term Debts|Utah Medical Products (UTMD) - Company Long-Term Debt|Company Long-Term Liabilities KORU Medical|NYXH (Nyxoah) - Company Long-Term Debts|Long-Term Debt Microbot Medical, Inc. MBOT|Company Long-Term Debt Pro-Dex Corp (PDEX)|Zentek Corp - Company Long-Term Indebtedness|Elutia Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities MLSS (milestonescientific.com)|NXGL - Company Long-Term Debt|Long-Term Debt Volume Retractable Technologies RVP|HBIO: Company Long-Term Debts|FEMY - Long-Term Debt Volume|Company Long-Term Debt Meihua Medical Technologies|Company Long-Term Indebtedness POAI (Predictive Oncology Corp)|Company Long-Term Debts CJMB|ATRI: Long-Term Liabilities|NeuroMetrix Corp - Company Long-Term Liabilities